PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-04-04

Date Title Company
04-Apr-2022 Bronchitis Treatment Market Top Players with Share, Product Scope, Total Revenues, Business Development and Opportunities till 2026 MARKITWIRED
04-Apr-2022 Cardiac Resynchronization Therapy Market Is Growing At A CAGR Of 7.9% During 2022-2032 MARKITWIRED Latest Market Reports
04-Apr-2022 Stanley Capital-backed portfolio company DSS acquires MyMeds&Me MyMeds&Me
04-Apr-2022 Arthroscopy Procedure and Products Market is poised to expand at over 7.7% CAGR during the forecast period, from 2021 to 2031. MARKITWIRED
04-Apr-2022 Antibodies Market to surpassing US$ 601.614 Billion by the end of 2031 MARKITWIRED
04-Apr-2022 Stool Management Systems Market is growing at a CAGR of 3.8 % for 2021 – 2031. MARKITWIRED
04-Apr-2022 Industrial Microbiology Market to reach a valuation of US$ 21.56 Billion by 2031 MARKITWIRED
04-Apr-2022 Female Pelvic Implants Market to exhibit growth at a CAGR of 2.8% between 2021 and 2031 MARKITWIRED
04-Apr-2022 Omnicell Agree Product Distributor Agreement with Hanmi Pharm Omnicell International
04-Apr-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Apr-2022 Oxytocic Pharmaceuticals Market to hit US$ 98.60 Mn in 2021, Says Future Market Insights (FMI) MARKITWIRED
04-Apr-2022 BRAIN Biotech AG: Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC) BRAIN Biotech AG
04-Apr-2022 BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC) BRAIN Biotech AG
04-Apr-2022 CardioRenal raises €3.3 million Andrew Lloyd Associates
04-Apr-2022 U.S. FDA Grants Priority Review to Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults Businesswire
04-Apr-2022 Aelis Farma Reports 2021 Annual Financial Results and Confirms Its 2022 Outlook Businesswire
04-Apr-2022 DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy Businesswire
04-Apr-2022 New Data for Genentech’s Ocrevus (ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis Businesswire
04-Apr-2022 B-Glucuronidase Enzymes Market to Reap Excessive Revenues by 2026 MARKITWIRED Latest Market Reports
04-Apr-2022 X-Linked Hypophosphatemia Market Expansion to be Persistent During 2026 MARKITWIRED Latest Market Reports